Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Long-Term Outcomes with 3-Dimensional Conformal External Beam Accelerated Partial Breast Irradiation.

Kennedy WR, Roach MC, Thomas MA, Ochoa L, Altman MB, Hernandez-Aya LF, Cyr AE, Margenthaler JA, Zoberi I.

Pract Radiat Oncol. 2019 Sep 18. pii: S1879-8500(19)30271-1. doi: 10.1016/j.prro.2019.09.007. [Epub ahead of print]

PMID:
31541717
2.

Treatment response as predictor for brain metastasis in triple negative breast cancer: A score-based model.

Gabani P, Weiner AA, Hernandez-Aya LF, Khwaja S, Roach MC, Ochoa LL, Mullen D, Thomas MA, Matesa MA, Margenthaler JA, Cyr AE, Naughton MJ, Ma C, Sanati S, Zoberi I.

Breast J. 2019 May;25(3):363-372. doi: 10.1111/tbj.13230. Epub 2019 Mar 28.

PMID:
30920124
3.

Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma.

Johnson DB, Bordeaux J, Kim JY, Vaupel C, Rimm DL, Ho TH, Joseph RW, Daud AI, Conry RM, Gaughan EM, Hernandez-Aya LF, Dimou A, Funchain P, Smithy J, Witte JS, McKee SB, Ko J, Wrangle JM, Dabbas B, Tangri S, Lameh J, Hall J, Markowitz J, Balko JM, Dakappagari N.

Clin Cancer Res. 2018 Nov 1;24(21):5250-5260. doi: 10.1158/1078-0432.CCR-18-0309. Epub 2018 Jul 18.

PMID:
30021908
4.

Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes.

Gabani P, Fischer-Valuck BW, Johanns TM, Hernandez-Aya LF, Keller JW, Rich KM, Kim AH, Dunn GP, Robinson CG, Chicoine MR, Huang J, Abraham CD.

Radiother Oncol. 2018 Aug;128(2):266-273. doi: 10.1016/j.radonc.2018.06.017. Epub 2018 Jun 27.

PMID:
29960685
5.

Chemotherapy principles of managing stage IV breast cancer in the United States.

Hernandez-Aya LF, Ma CX.

Chin Clin Oncol. 2016 Jun;5(3):42. doi: 10.21037/cco.2016.04.01. Epub 2016 Apr 14. Review.

6.

Why Chemotherapy Should be Given Early for Men with Metastatic Prostate Cancer.

Hernandez-Aya LF, Hussain M.

Am Soc Clin Oncol Educ Book. 2015:e263-9. doi: 10.14694/EdBook_AM.2015.35.e263.

7.

A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease.

Donath E, Chaudhry A, Hernandez-Aya LF, Lit L.

Respir Med. 2013 Sep;107(9):1385-92. doi: 10.1016/j.rmed.2013.05.004. Epub 2013 Jun 12. Review.

8.

Adjuvant systemic therapies in breast cancer.

Hernandez-Aya LF, Gonzalez-Angulo AM.

Surg Clin North Am. 2013 Apr;93(2):473-91. doi: 10.1016/j.suc.2012.12.002. Epub 2013 Feb 8. Review.

PMID:
23464697
9.

Triple-negative breast cancer is not a contraindication for breast conservation.

Adkins FC, Gonzalez-Angulo AM, Lei X, Hernandez-Aya LF, Mittendorf EA, Litton JK, Wagner J, Hunt KK, Woodward WA, Meric-Bernstam F.

Ann Surg Oncol. 2011 Oct;18(11):3164-73. doi: 10.1245/s10434-011-1920-z. Epub 2011 Sep 27.

10.

Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers.

Raghav KP, Hernandez-Aya LF, Lei X, Chavez-Macgregor M, Meric-Bernstam F, Buchholz TA, Sahin A, Do KA, Hortobagyi GN, Gonzalez-Angulo AM.

Cancer. 2012 Mar 15;118(6):1498-506. doi: 10.1002/cncr.26431. Epub 2011 Aug 11.

11.

Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer.

Hernandez-Aya LF, Chavez-Macgregor M, Lei X, Meric-Bernstam F, Buchholz TA, Hsu L, Sahin AA, Do KA, Valero V, Hortobagyi GN, Gonzalez-Angulo AM.

J Clin Oncol. 2011 Jul 1;29(19):2628-34. doi: 10.1200/JCO.2010.32.1877. Epub 2011 May 23.

12.

Targeting the phosphatidylinositol 3-kinase signaling pathway in breast cancer.

Hernandez-Aya LF, Gonzalez-Angulo AM.

Oncologist. 2011;16(4):404-14. doi: 10.1634/theoncologist.2010-0402. Epub 2011 Mar 15. Review.

Supplemental Content

Loading ...
Support Center